Skip to search formSkip to main contentSkip to account menu

monatepil

Known as: 11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate, (+/-)-N-(6,11-Dihydrodibenzo(B,E)Thiepin-11-yl)-4-(P-Fluorophenyl)-1-Piperazinebutyramide, 1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
A number of new classes of antihypertensive drugs have become available in the recent years which appear to hold therapeutic… 
1995
1995
Summary: Monatepil, a novel calcium antagonist, has α1-adrenoceptor blocking activity; in the present study, we examined the… 
1994
1994
The effects of monatepil, a new calcium antagonist with alpha 1-blocking activity, and nitrendipine on lipoprotein and… 
1994
1994
In two studies on the same group of patients we evaluated noninvasive methods of assessing atherosclerosis and determined the… 
1994
1994
The action of the novel antihypertensive calcium antagonist monatepil on the hepatic LDL receptor was investigated at the gene… 
Review
1994
Review
1994
  • M. Miyazaki
  • American Journal of Hypertension
  • 1994
  • Corpus ID: 25899861
Traditional antihypertensive therapy has been shown to reduce the incidence of hypertension-related vascular injuries; however… 
1994
1994
1. The preventive effects of atherosclerosis and hyperlipidemia of monatepil ([(+-)-N-(6,11-dihydrodibenzo [b,e]thiepin-11-yl)-4… 
1993
1993
Effects of monatepil ([(+/-)-N-(6,11-dihydrodibenzo[b, e]thiepin-11-yl)-4-(p-fluorophenyl)-1-piperazinebutyramide]m aleate, AJ… 
1993
1993
1. The preventive effects of monatepil, a new calcium antagonist with α1‐adrenoceptor blocking activity, on ischaemic…